<p>(<b>A</b>) 435s/M14 cells, transfected with STAT3 siRNA, were drug treated (8 h), and nuclear fractions analyzed by Western blot. Graph is Mean±SEM from 3 independent experiments. (<b>B</b>) 435s/M14 cells stably expressing pcDNA or STAT3C were drug treated (8 h), and nuclear fractions analyzed by Western blot. Graph is Mean±SEM of 3 independent experiments. (<b>C</b>) Lysates from drug-treated pcDNA and STAT3C-expressing cells (40 h), were analyzed by Western blot. Graphs are Mean±SEM from 3 independent experiments. For all subfigures, some error bars are too small to visualize. *<i>p</i><0.05, **<i>p</i>≤0.01 (see methods).</p
<p>(<b>A</b>) Cells were treated with imatinib (72 h), washed, treated with doxorubicin (30′) in the...
<p>Immunoblot analyses showing (A) nuclear translocation of NF-κB (p65), (B) phospho-IKKα/β, phospho...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>(<b>A, B</b>) 435s/M14 cells were treated with imatinib (10 µM) (<b>A</b>) or transfected with ST...
<p>Western blot analysis of NFκB members p65 and IκBα in non-differentiated (St-T1, first line; KdS1...
<p>(A) Western blot analysis to see the nuclear and cytosolic expression of NF-κB in MDA-MB 231 cell...
<p><b>A.</b> The cells were treated with 100 U/ml IFN-γ for 16 hrs. p65 and DAPI double labeling and...
<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), ...
<p><b>A</b>. Western blot analysis for the NF-κB (p65) expression level in different genetically mod...
<p>Imatinib prevents activation of STAT3, which promotes doxorubicin-mediated NF-κB phosphorylation ...
<p>A to C shows FCM analysis of HCE-T cells treated with BMS-345541 (5 µM), a NF-κB pathway inhibito...
<p>Caspase-3/7 activity (<b>A,B,E</b>), Annexin V staining (<b>C</b>), or PARP cleavage (<b>D,F</b>)...
<p>A, Representative fluorescent images of p65 localization at various time points following IGF-1 t...
<p>(A) LX-2 cells were transfected with miR-C, miR-122, si-C or si-PACT. Thirty-six hours post-trans...
<p>(<b>A</b>) Cells were treated with imatinib (72 h), washed, treated with doxorubicin (30′) in the...
<p>Immunoblot analyses showing (A) nuclear translocation of NF-κB (p65), (B) phospho-IKKα/β, phospho...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...
<p>(<b>A</b>) Nuclear lysates from doxorubin (0.5 µM-top; 1 µM-bottom)/imatinib (10 µM)-treated 435s...
<p>(<b>A, B</b>) 435s/M14 cells were treated with imatinib (10 µM) (<b>A</b>) or transfected with ST...
<p>Western blot analysis of NFκB members p65 and IκBα in non-differentiated (St-T1, first line; KdS1...
<p>(A) Western blot analysis to see the nuclear and cytosolic expression of NF-κB in MDA-MB 231 cell...
<p><b>A.</b> The cells were treated with 100 U/ml IFN-γ for 16 hrs. p65 and DAPI double labeling and...
<p>(A) Soft agar colony formation assay was performed in K562 cells after treatment with NC (4 μM), ...
<p><b>A</b>. Western blot analysis for the NF-κB (p65) expression level in different genetically mod...
<p>Imatinib prevents activation of STAT3, which promotes doxorubicin-mediated NF-κB phosphorylation ...
<p>A to C shows FCM analysis of HCE-T cells treated with BMS-345541 (5 µM), a NF-κB pathway inhibito...
<p>Caspase-3/7 activity (<b>A,B,E</b>), Annexin V staining (<b>C</b>), or PARP cleavage (<b>D,F</b>)...
<p>A, Representative fluorescent images of p65 localization at various time points following IGF-1 t...
<p>(A) LX-2 cells were transfected with miR-C, miR-122, si-C or si-PACT. Thirty-six hours post-trans...
<p>(<b>A</b>) Cells were treated with imatinib (72 h), washed, treated with doxorubicin (30′) in the...
<p>Immunoblot analyses showing (A) nuclear translocation of NF-κB (p65), (B) phospho-IKKα/β, phospho...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...